![John Henneman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Henneman
Directeur/Membre du Conseil chez
APREA THERAPEUTICS, INC.
Fortune : 2 M $ au 31/08/2026
Profil
Mr. John B. Henneman, III, is an Independent Director at Orthofix Medical, Inc., a Lead Independent Director at Anika Therapeutics, Inc. and a Lead Independent Director at Aprea Therapeutics, Inc. He is on the Board of Directors at Orthofix Medical, Inc., Anika Therapeutics, Inc., Aprea Therapeutics AB, Aprea Therapeutics, Inc. and Alafair Biosciences, Inc. Mr. Henneman was previously employed as a Lead Independent Director by R1 RCM, Inc., an Independent Director by SeaSpine Holdings Corp., a Chief Financial Officer, Secretary & Executive VP by NewLink Genetics Corp., a Chief Financial Officer by Integra LifeSciences Holdings Corp., an Interim Co-Chief Executive Officer & Secretary by Neuromedical Systems, Inc., and a Chairman by New Deal Technology SAS. He received his undergraduate degree from Princeton University and a graduate degree from The University of Michigan Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANIKA THERAPEUTICS, INC. 0,49 % | 18/06/2026 | 65 273 ( 0,49 % ) | 1 M $ | 31/08/2026 |
| 10/06/2026 | 42 462 ( 0,1 % ) | 398 718 $ | 31/08/2026 | |
APREA THERAPEUTICS, INC. 0,08 % | 16/06/2026 | 10 229 ( 0,08 % ) | 8 183 $ | 31/08/2026 |
Postes actifs de John Henneman
| Sociétés | Poste | Début |
|---|---|---|
| APREA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2019 |
| ANIKA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2026 |
| ORTHOFIX MEDICAL INC. | Directeur/Membre du Conseil | 05/01/2023 |
Alafair Biosciences, Inc.
 Alafair Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops naturally-derived biopolymer technologies to reduce scarring, enhance mobility and accelerate patient recovery | Directeur/Membre du Conseil | 01/01/2015 |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Directeur/Membre du Conseil | 01/08/2019 |
Anciens postes connus de John Henneman
| Sociétés | Poste | Fin |
|---|---|---|
| R1 RCM INC. | Directeur/Membre du Conseil | 19/11/2024 |
| SEAE HLDG | Directeur/Membre du Conseil | 05/01/2023 |
| LUMOS PHARMA, INC. | Directeur Financier/CFO | 26/07/2018 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Directeur Financier/CFO | 01/09/2014 |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de John Henneman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Neuromedical Systems, Inc.
 Neuromedical Systems, Inc. Medical SpecialtiesHealth Technology Develops, makes and markets a supplemental test to aid laboratories in the detection of abnormal cells | Health Technology |
Orthofix Medical, Inc.
 Orthofix Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets surgical products to the spine & orthopedic markets | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Alafair Biosciences, Inc.
Alafair Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops naturally-derived biopolymer technologies to reduce scarring, enhance mobility and accelerate patient recovery | Commercial Services |
SeaSpine Holdings Corp.
 SeaSpine Holdings Corp. Medical SpecialtiesHealth Technology Designs, develops and sells surgical solutions for the treatment of patients suffering from spinal disorders | Health Technology |
New Deal Technology SAS
 New Deal Technology SAS Medical SpecialtiesHealth Technology Develops and manufactures specialty implants and instruments for foot and ankle surgery | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
R1 RCM, Inc.
 R1 RCM, Inc. Packaged SoftwareTechnology Services Develops as a healthcare revenue cycle management platform | Technology Services |
The University of Michigan Law School
 The University of Michigan Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
